DOW INC
For the period ended Sep 30, 2024. Filed Oct 25, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Oct 25, 2024
DOW$31.48+1.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Equity
| Three Months Ended | Nine Months Ended | |||
|---|---|---|---|---|
| In millions (Unaudited) | Sep 30,2024 | Sep 30,2023 | Sep 30,2024 | Sep 30,2023 |
| Common Stock | ||||
| Balance at beginning and end of period | $— | $— | $— | $— |
| Additional Paid-in Capital | ||||
| Balance at beginning of period | 9,341 | 8,822 | 9,091 | 8,627 |
| Issuance of parent company stock - Dow Inc. | — | 8 | 51 | 63 |
| Stock-based compensation | 86 | 77 | 285 | 217 |
| Balance at end of period | 9,427 | 8,907 | 9,427 | 8,907 |
| Retained Earnings | ||||
| Balance at beginning of period | 16,964 | 18,469 | 17,495 | 19,472 |
| Net income available for The Dow Chemical Company common stockholder | 224 | 285 | 1,186 | 672 |
| Dividends to Dow Inc. | (600) | (630) | (2,077) | (2,008) |
| Other | (3) | (5) | (19) | (17) |
| Balance at end of period | 16,585 | 18,119 | 16,585 | 18,119 |
| Accumulated Other Comprehensive Loss | ||||
| Balance at beginning of period | (7,785) | (7,067) | (7,681) | (7,139) |
| Other comprehensive income (loss) | 282 | (194) | 178 | (122) |
| Balance at end of period | (7,503) | (7,261) | (7,503) | (7,261) |
| The Dow Chemical Company's stockholder's equity | 18,509 | 19,765 | 18,509 | 19,765 |
| Noncontrolling Interests | 530 | 513 | 530 | 513 |
| Total Equity | $19,039 | $20,278 | $19,039 | $20,278 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.